Cost-utility of sintilimab plus chemotherapy vs chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction cancer in China
Article in Expert Review of Pharmacoeconomics & Outcomes Research (April 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Expert Review of Pharmacoeconomics & Outcomes Research (April 2024)
Preprint in Research Square (March 2024)
Preprint in Research Square (February 2024)